TX-MARY-KAY
14.5.2024 18:01:36 CEST | Business Wire | Press release
Mary Kay Inc., a corporate leader in global sustainability, is strengthening its roots in Lewisville. On May 10, the company partnered with the Arbor Day Foundation and Keep Lewisville Beautiful to host a tree planting event at Railroad Park to celebrate Mother Nature and Mother’s Day.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240514127551/en/
Trees planted at Railroad Park directly impact Lewisville communities by providing important ecosystem benefits in the Trinity River watershed. (Photo: Mary Kay Inc.)
“Through partnerships with organizations like the Arbor Day Foundation, Mary Kay is making positive environmental impact in ecosystems where we operate around the world,” said Ryan Rogers, CEO of Mary Kay, Inc., and grandson of Mary Kay Ash. “But change starts in your own backyard. We enjoyed ‘sprucing’ up the community by planting trees that will benefit local families for generations to come.”
Mary Kay volunteers planted 60 native trees along the trails and waterways in Railroad Park, symbolizing the company’s 60th anniversary of enriching the lives of women and their families worldwide and protecting the planet. The park is four miles from Mary Kay’s state-of-the-art Richard R. Rogers (R3) Manufacturing/R&D Center. Trees planted at this location directly impact Lewisville communities by providing much-needed shade in community spaces, enhancing the beautification of recreational areas, and providing important ecosystem benefits in the Trinity River watershed.
"We are thrilled to see Mary Kay contribute to the tree canopy of Lewisville,” said TJ Gilmore, Mayor of Lewisville. “This initiative is not only a breath of fresh air for our city but a testament to the flourishing partnership between our community and a corporation that continuously gives back. Together, we’re making Lewisville a better place to live and work."
Mary Kay’s partnership with the Arbor Day Foundation stretches back more than 16 years—and in that time, the company has helped plant 1.4 million trees around the world. Arbor Day Foundation is the world’s largest membership nonprofit dedicated to planting trees.
“The Arbor Day Foundation is dedicated to helping our local planting partners unlock the transformative power of trees in their community,” said Dan Lambe, Chief Executive of the Arbor Day Foundation. “Trees clean our air, cool our cities, and improve the lives of the people around them. We’re happy to partner again with Mary Kay and Keep Lewisville Beautiful to maximize the impact of the urban canopy and inspire more people to engage with nature in a meaningful way.”
Keep Lewisville Beautiful is a local environmental nonprofit that partners with organizations to plant trees and provide residents opportunities to care for Lewisville’s tree canopy on public lands.
“Tree planting is an investment in our community’s future,” said Amy Wells, Executive Director of Keep Lewisville Beautiful. “These trees will help create shade for families visiting Railroad Park, provide habitat to local wildlife, and will provide a multitude of ecological benefits for our local environment. Keep Lewisville Beautiful is excited to partner with Mary Kay and the Arbor Day Foundation to increase Lewisville’s tree canopy and make a visible difference in our community with Mary Kay volunteers. Their donation to our community and KLB will go a long way towards keeping Lewisville beautiful.”
Following the planting, the Lewisville Parks Department is committed to long-term maintenance and upkeep of the trees with supplemental watering, pruning, and care.
Did you know:
- R3 Manufacturing/R&D Center in Lewisville is named in honor of Mary Kay Inc.’s cofounder and Mary Kay Ash’s son, Richard R. Rogers.
- Built on 26 acres of land, R3 features state-of-the-art R&D laboratories and cutting-edge manufacturing technology.
- 57% of products manufactured at R3 are exported to Mary Kay’s international markets.
- R3 production capacity is up to 1.1 million products per day. The facility boasts 20 product-packaging lines and 21 processing vessels and mixing tanks.
- R3 is LEED Building Design and Construction Silver-Certified facility.
About Mary Kay
Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
About the Arbor Day Foundation
Founded in 1972, the Arbor Day Foundation is the largest nonprofit membership organization dedicated to planting trees. Together with our partners, we have helped plant more than 500 million trees in neighborhoods, communities, cities, and forests throughout the world. Our vision is to lead toward a world where trees are used to solve issues critical to survival. Through our members, partners and programs, the Arbor Day Foundation inspires people across the globe to plant, nurture and celebrate trees. More information is available at arborday.org.
About Keep Lewisville Beautiful
Keep Lewisville Beautiful (KLB) is a non-profit and award-winning affiliate of Keep America Beautiful and Keep Texas Beautiful. KLB’s mission is to “engage the citizens of Lewisville through service and education to enhance their community environment”. Our vision is to partner with the community to promote environmental quality, making Lewisville the best place to live, work, and play. Annually, KLB volunteers contribute over 10,000 volunteer hours towards litter abatement, environmental education, and beautification programs, and remove 25+ TONS of trash from community green spaces and waterways. Learn more at keeplewisvillebeautiful.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514127551/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
